Femy stock news
FEMASYS INC (FEMY): $0.90 0.05 (-5.05%) POWR Rating Get Rating Component Grades Growth Get Rating Value Get Rating Momentum D Stability F Sentiment Get Rating …06/26/2023 - 08:00 AM - Pivotal clinical trial to begin in the third quarter of 2023-. ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women’s needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, announced today the approval of an Investigational ...
Did you know?
FEMY Femasys Inc Form D - Notice of Exempt Offering of Securities ... Stocks; Commodities; Forex; Cryptocurrency; The Lounge; News. InvestorsHub Newswire; All Company News; iHub Market News; News Scanner; Price and News Alerts; Investorshub Daily; Newsletters; Market Data. Monitor; Level 2; ... My Stocks Activity; Ticker Buzz …That’s closing in on its daily average trading volume of about 210,000 shares. The company’s stock is also down 5.5% as of Tuesday morning. Adding to this, SGBXV stock is down 26.6%, while ...FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year-to-date. Investors searching for all of the most recent stock market stories on Tuesday are going to want to ...
Oct 2, 2023 · Recent News. The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre-market session. It has soared by over 1,257% from the lowest level in September, giving it a market cap of nearly $50 million. An FDA Calendar typically displays information about the expected timeline for a particular drug approval or PDUFA date. The calendar will also provide key information such as what type of approval is being sought (e.g. full approval, tentative approval, accelerated approval), and any publicly available information about the expected decision ...06/26/2023 - 08:00 AM - Pivotal clinical trial to begin in the third quarter of 2023-. ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women’s needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, announced today the approval of an Investigational ...The average price estimated by analysts for FEMY is $8.50, which is $7.56 above than the current price. The public float for FEMY is 19.48M, and at present, short sellers hold a 1.47% of that float. The average trading volume of FEMY on November 30, 2023 was 10.37M shares. Top 5 EV Tech Stocks to Buy for 2023.26 Sep 2023 ... Here I Show FEMY Stock (Femasys stock) FEMY STOCK PREDICTION FEMY STOCK analysis FEMY stock news today and also femy stock forecast ...
Operating Status Active. Last Funding Type Post-IPO Debt. Legal Name Femasys Inc. Stock Symbol NASDAQ:FEMY. Company Type For Profit. Contact Email [email protected]. Phone Number 1 (770) 500-3910. Femasys is a biomedical company focused on transforming women’s healthcare worldwide by developing novel …Femasys has an Altman Z-Score of -8.87 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy. Detailed statistics for Femasys Inc. (FEMY) stock, including valuation metrics, financial numbers, share information and more.Find the latest news headlines from Femasys Inc. Common Stock (FEMY) at Nasdaq.com. …
Reader Q&A - also see RECOMMENDED ARTICLES & FAQs. THAR Stock Movement Today. With the name change comes an increased. Possible cause: At Yahoo Finance, you get free stock quotes, up-to-date...
FEMY stock is up 180.9% as of Tuesday morning after closing out Monday down 63.2% year-to-date. Investors searching for all of the most recent stock market stories on Tuesday are going to want to ...The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.05 A.M. ET). Orchard Therapeutics plc ( ORTX) is up over 97% at $15.95. Grom Social Enterprises, Inc. ( GROM) is up over 27% at $2.23. Femasys Inc. ( FEMY) is up over 24% at $2.85.The average price estimated by analysts for FEMY is $8.50, which is $7.56 above than the current price. The public float for FEMY is 19.48M, and at present, short sellers hold a 1.47% of that float. The average trading volume of FEMY on November 30, 2023 was 10.37M shares. Top 5 EV Tech Stocks to Buy for 2023.
FEMY Femasys Inc Form 8-K - Current report false000133900500013390052023-09-252023-09-25 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPOR...Find the latest CISO Global Inc. (CISO) stock quote, history, news and other vital information to help you with your stock trading and investing.Oct 2, 2023 · One of the more recent movers in the stock market is Femasys Inc. (NASDAQ: FEMY). Shares of the biotech company’s shares have exploded from around $0.30 to highs of $4.75 within a matter of days. However, if you look at trading action in the stock market today, you’ll see that big gains can quickly turn into significant losses.
bank stock Oct 4, 2023 · Publish : 04 Oct 2023, 07:17 PM Update : 04 Oct 2023, 07:17 PM. Femasys (NASDAQ: FEMY) stock is down 50% over night from highs. A reasonable bet would be that FEMY stock will continue to fall back to more reasonable levels. For, as far as we can see at least, this is a flurry of speculation producing far too much movement for the objective ... best app for short term tradingbond quotes Real stock prices are not the same as the last traded stock price. Real stock prices are adjustments to closing stock prices. The adjustments are used in a variety of ways, including dividends, the range of prices and the closing price of t...Find the latest news headlines from Femasys Inc. Common Stock (FEMY) at Nasdaq.com. uti price Fintel. Fintel reports that on September 26, 2023, JonesTrading maintained coverage of Femasys (NASDAQ:FEMY) with a Buy recommendation. Analyst Price Forecast Suggests 1,553.35% Upside As of ...06/26/2023 - 08:00 AM - Pivotal clinical trial to begin in the third quarter of 2023-. ATLANTA, June 26, 2023 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a biomedical company aiming to meet women’s needs worldwide by developing a suite of product candidates that include minimally invasive, in-office technologies for reproductive health, announced today the approval of an Investigational ... delorean alpha 5.best broker to trade optionsdental discount plan vs insurance Nov 24, 2023 · Complete Femasys Inc. stock information by Barron's. View real-time FEMY stock price and news, along with industry-best analysis. api report crude Enter your email address below to receive the latest news and earnings results for FEMY and its competitors with MarketBeat's FREE daily newsletter. FEMY Earnings Date and Information Femasys has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, April 4th, 2024 …About FEMY. our experienced management team has over 200 years of collective industry experience with extensive focus in medical devices. the pioneering and collaborative efforts of the management team have created an organization that strives for integrity in all actions, innovation in development activities, excellence in operations, and the ... nasdaq playexdividend dateavgo nasdaq The remarkable Femasys (NASDAQ: FEMY) stock price comeback continued on Monday as demand for the shares continued. The shares surged by more than 45% on Friday and gained by another 15% in the pre ...